Diabetes risk associated with use of olanzapine, quetiapine, and risperidone in veterans health administration patients with schizophrenia. [electronic resource]
Producer: 20061027Description: 672-81 p. digitalISSN:- 0002-9262
- Antipsychotic Agents -- adverse effects
- Benzodiazepines -- adverse effects
- Case-Control Studies
- Cohort Studies
- Diabetes Mellitus, Type 2 -- epidemiology
- Dibenzothiazepines -- adverse effects
- Female
- Humans
- Male
- Middle Aged
- Olanzapine
- Proportional Hazards Models
- Quetiapine Fumarate
- Regression Analysis
- Risk Factors
- Risperidone -- adverse effects
- Schizophrenia -- drug therapy
- United States -- epidemiology
- Veterans
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.